World Class Capabilities in the Heart of the Biologics Manufacturing Universe
World Class Facility in the Heart of the Biologics Manufacturing Universe
Our proprietary high-efficiency manufacturing platform, STRIPE™ (System to Realize Improved Production Efficiency), integrates advances in cell line technology and upstream and downstream process to achieve exponential reductions in production costs at scale. We are developing reliable and robust production systems with the potential to deliver substantially higher amounts of AAV product per batch.
Our 51,000 square foot manufacturing facility is located in Research Triangle Park, North Carolina, one of the global centers for the manufacturing of biological therapies. The facility is designed to support the production of material from early research through commercial launch of Kriya’s products, with its own fully integrated process development lab, pilot production suite, and current good manufacturing (cGMP) production capability. Our cGMP production suites and single-use systems will support the production of multiple products simultaneously at up to 3,000-liter bioreactor, with full in-house fill/finish and quality control testing and release capabilities.
The facility’s research-grade production and pilot production suite are currently online, with its full cGMP manufacturing infrastructure coming online in 2021.